 |
 |
11:15 A.M.-12:15 P.M
Meet the Experts
Advances in Cord Blood Transplantation
Eliane Gluckman Eurocord/Saint-Louis Hospital, Paris France6:00 PM - 8:00 PM
Poster Session: Cell Processing
2155 Use of Aldehyde Dehydrogenase Content to Predict Dominating Cord in Double Cord Blood Transplant. Kristin M Page, et al.
2159 Enrichment of Mononuclear Cells From Cryopreserved Cord Blood Units Using the Purecell™ Select System. Bryan P Spencer et al.
2160 Colony Forming Unit (CFU) Assay with High Resolution Digital Imaging (HRDI): a Reliable, Standardized Technology for Evaluation of Cord Blood Potency Before and After Cryopreservation. Maria S Albano, et al.
Poster Session: Clinical Results - Alternative Donor Transplantation
2295 Comparative Single-Institute Analysis of Cord Blood Transplantation From Unrelated Donors with Related Bone Marrow or Peripheral Blood Stem-Cell Transplants in Elderly Patients with Hematologic Diseases After Reduced Intensity-Conditioning Regimen. Naoyuki Uchida, et al.
2296 Disease-Free Survival After Cord Blood (CB) Transplantation Is Not Different to That After Related or Unrelated Donor Transplantation in Patients with Hematologic Malignancies. Doris Ponce, et al.
2297 HLA Match and Mismatch Direction in Cord Blood (CB) Transplantation: Impact On Outcome and Implications for Cord Blood Unit Selection. Cladd Stevens, et al.
2298 Impact of ABO Imcompatibility On Acute GvHD and Thrombotic Microangiopathy After Reduced-Intensity Cord Blood Transplantation. Masanori Tsuji, et al.
2300 Outcomes After Related and Unrelated Umbilical Cord Blood Transplantation for Congenital Bone Marrow Failure Syndromes Other Than Fanconi Anemia. Renata Bizzetto, et al.
2301 Outcomes of Unrelated Cord Blood Transplantation for Non-Malignant Diseases in Children Are Not Associated with KIR-Ligand Matching Between Donor and Recipient: a Study On Behalf of Eurocord. Annalisa Ruggeri, et al.
2304 Reduced Toxicity Conditioning (RTC) Compared to Myeloablative Conditioning (MAC) Prior to Unrelated Cord Blood Transplantation (UCBT) in Pediatric Recipients Was Associated with Similar but Also Delayed Time to Immune Reconstitution and a Concomitant Significant Decrease in Grade II-IV Agvhd. Jason Freedman, et al.Oral and Poster Abstracts
Poster Session: Clinical Care - Acute and Chronic GVHD, Infectious Complications and Immune Reconstitution of Transplantation Poster II
2222 Early Immune Recovery Predicts Overall and Disease-Free Survival After Allogeneic Hematopoietic Stem Cell Transplantation. Jenna D. Goldberg.
Poster Session
Hemoglobinopathies, excluding Thalassemia Poster II
2555 Brain Imaginig in SCD Adults Patients: Correlation to TCD Image and Atoxic Contrast (Microbubbles). Paulo Bahia, et al.
2560 Extracranial Internal Carotid Arterial Disease in Children with Sickle Cell Disease. David C Rees. et al.
2579 Proteomic-Based Approach for Biomarker Discovery to Predict Silent Cerebral Infarct in Patients with Sickle Cell Disease. Lisa M. Williams, et al.